8-KLeadership ChangesShareholder MattersCorporate Changes+1

Edwards Lifesciences Corp 8-K Report, Executive Changes (May 15, 2023)

Filed May 15, 2023For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences (EW) details several key events that occurred around their 2023 Annual Meeting of Stockholders on May 10th, 2023. Most notably, the company announced an increase in CEO Bernard J. Zovighian's annual base salary to $1,050,000 and an incentive pay target of $1,470,000. This compensation adjustment reflects his prior appointment as Chief Executive Officer. Furthermore, the filing reports on the outcomes of various shareholder proposals. All director nominees were elected, and shareholders approved the company's executive compensation on an advisory basis, favoring annual "say-on-pay" votes. A significant amendment to the company's Certificate of Incorporation to provide exculpation for officers, as permitted by Delaware law, was also approved by stockholders. However, a shareholder proposal requesting an independent board chairman policy was not approved. The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2023 was also ratified.

Key Highlights

  • 1CEO Bernard J. Zovighian's annual base salary increased to $1,050,000, with an incentive pay target of $1,470,000.
  • 2All director nominees presented at the 2023 Annual Meeting were elected.
  • 3Stockholders approved the company's executive compensation on an advisory basis ('say-on-pay').
  • 4Shareholders approved an amendment to the Certificate of Incorporation for officer exculpation.
  • 5An advisory vote on the frequency of executive compensation votes resulted in 'one year' as the preferred frequency.
  • 6PricewaterhouseCoopers LLP ratified as the independent registered public accounting firm for FY 2023.
  • 7Shareholder proposal for an independent board chairman policy was not approved.

Frequently Asked Questions

The filing reports an increase in CEO Bernard J. Zovighian's annual base salary to $1,050,000 and an increase in his incentive pay objective under the annual cash incentive plan to $1,470,000, effective May 11, 2023.

Shareholders elected all director nominees, approved the company's executive compensation on an advisory basis (say-on-pay), and favored holding advisory votes on executive compensation annually. They also approved an amendment to the Certificate of Incorporation for officer exculpation and ratified PricewaterhouseCoopers LLP as the independent auditor. A proposal for an independent board chairman policy was not approved.

This amendment allows the company to exculpate its officers from certain liabilities, as permitted by Delaware General Corporation Law. This can be seen as a measure to protect officers and potentially attract and retain talent by reducing personal financial risk for certain actions taken in their capacity as officers.

Based on the voting results, the company will hold an advisory vote on executive compensation annually for each annual meeting of stockholders.